FDA Orange Book
Generic for Fycompa
Fycompa contains perampanel. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Fycompa is perampanel. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Fycompa and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Fycompa products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| suspension, oral | 0.5MG/ML | Marketed (Rx) | AB | 2 | AB |
| tablet, oral | 10MG | Marketed (Rx) | AB | 4 | AB |
| tablet, oral | 12MG | Marketed (Rx) | AB | 4 | AB |
| tablet, oral | 2MG | Marketed (Rx) | AB | 4 | AB |
| tablet, oral | 4MG | Marketed (Rx) | AB | 4 | AB |
| tablet, oral | 6MG | Marketed (Rx) | AB | 4 | AB |
| tablet, oral | 8MG | Marketed (Rx) | AB | 4 | AB |
NDA 208277, 202834, held by CATALYST PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic perampanel
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| TEVA PHARMACEUTICALS USA INC | 209801 | AB (A-rated, therapeutically equivalent) | May 23, 2025 | 10MG, 12MG, 2MG, 4MG, 6MG, 8MG |
| MSN LABORATORIES PRIVATE LTD | 218152 | AB (A-rated, therapeutically equivalent) | July 11, 2025 | 0.5MG/ML |
| MSN LABORATORIES PRIVATE LTD | 218178 | AB (A-rated, therapeutically equivalent) | November 25, 2025 | 10MG, 12MG, 2MG, 4MG, 6MG, 8MG |
| TARO PHARMACEUTICAL INDUSTRIES LTD | 209538 | AB (A-rated, therapeutically equivalent) | November 25, 2025 | 10MG, 12MG, 2MG, 4MG, 6MG, 8MG |
| TARO PHARMACEUTICAL INDUSTRIES LTD | 219052 | AB (A-rated, therapeutically equivalent) | June 15, 2026 | 0.5MG/ML |
| AUROBINDO PHARMA LTD | 220492 | AB (A-rated, therapeutically equivalent) | October 2, 2026 | 10MG, 12MG, 2MG, 4MG, 6MG, 8MG |
Fycompa patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 8772497 | July 1, 2026 | Drug substance | None | 208277 |
Fycompa NDC codes
Questions
Is there a generic for Fycompa?
Yes. The generic name for Fycompa is perampanel. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Fycompa?
The active ingredient in Fycompa is perampanel, per the FDA Orange Book.
When does the Fycompa patent expire?
The last patent listed for Fycompa in the Orange Book expires July 1, 2026. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Fycompa and Perampanel
- What is Fycompa used for?FDA label uses
- Is Fycompa a controlled substance?Schedule III
- What is Perampanel used for?FDA label uses
- Is Perampanel a controlled substance?Schedule III
- Noncompetitive AMPA Glutamate Receptor Antagonists listFDA drug class
- NDC 62856-272Fycompa NDC record
- NDC 62856-274Fycompa NDC record
- NDC 62856-276Fycompa NDC record
- Schedule III drugs listDEA schedule